X-48904779-C-G
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_005660.3(SLC35A2):āc.1130G>Cā(p.Arg377Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000992 in 1,209,745 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R377H) has been classified as Likely benign.
Frequency
Consequence
NM_005660.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC35A2 | NM_005660.3 | c.1130G>C | p.Arg377Pro | missense_variant | 4/5 | ENST00000247138.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC35A2 | ENST00000247138.11 | c.1130G>C | p.Arg377Pro | missense_variant | 4/5 | 1 | NM_005660.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000179 AC: 2AN: 111995Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34163
GnomAD3 exomes AF: 0.0000110 AC: 2AN: 182268Hom.: 0 AF XY: 0.0000299 AC XY: 2AN XY: 66850
GnomAD4 exome AF: 0.00000911 AC: 10AN: 1097750Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 4AN XY: 363124
GnomAD4 genome AF: 0.0000179 AC: 2AN: 111995Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34163
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 08, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
SLC35A2-congenital disorder of glycosylation Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 11, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at